Public Workshop on Burkholderia

November 29-30, 2012 FDA White Oak Headquarters 10903 New Hampshire Ave Silver Spring, MD, 20993   Day one: 8 a.m. - 5 p.m.  EST Day two: 8 a.m. - 12 p.m. EST   Registration is now closed. If you have any questions, please contact: AskMCMi@fda.hhs.gov Workshop Agenda and Program 10.25 CEs Will Be Offered!

On Nov. 29-30, 2012, FDA’s Medical Countermeasures initiative (MCMi) is sponsoring a Public Workshop on Burkholderia (see also Federal Register notice) in collaboration with the:

• Defense Threat Reduction Agency;
• National Institutes of Health;
• Centers for Disease Control and Prevention;
• U.S. Army Medical Research Institute of Infectious Diseases;
• Biomedical Advanced Research and Development Authority;
• Chemical Biological Medical Systems Joint Project Management Office;
• U.S. Strategic Command Center for Combating Weapons of Mass Destruction; and
• Joint Science and Technology Office for Chemical and Biological Defense.

The workshop will present the latest information on melioidosis (caused by Burkholderia pseudomallei) and glanders (caused by Burkholderia mallei), building on previous meetings and identifying areas of research needed to advance animal model development and candidate medical countermeasures (MCMs) for approval, licensure, or clearance.

Suggested preparatory reading material for the workshop: